Human epidermis is a novel site of phospholipase B expression
2002
Biochem Biophys Res Commun 2002 ;295 (2):362-9 | Institut de recherche Pierre Fabre, CERPER/Hotel Dieu Saint Jacques, F31052 Toulouse, France.
Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):31-9 | L'Oreal Research, Aulnay-sous-Bois, France. [email protected]
In vitro evaluation of skin sensitivity of povidone-iodine and other antiseptics using a three-dimensional human skin model
2002
Dermatology 2002 ;204 Suppl 1):109-13 | Pharmaceutical Research Center, Meiji Seika Kaisha, Yokohama, Japan. [email protected]
Keratinocytes control the pheo/eumelanin ratio in cultured normal human melanocytes
2002
Pigment Cell Res 2002 ;15 (6):440-6 | L'Oreal Recherche, Clichy, France. [email protected]
Kinetic analysis on the in vitro cytotoxicity using Living Skin Equivalent for ranking the toxic potential of dermal irritants
2002
Toxicol In Vitro 2002 ;16 (6):759-63 | Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan. [email protected]
A long-term coculture model for the study of mast cell-keratinocyte interactions
2002
J Invest Dermatol 2002 ;119 (2):411-5 | Department of Dermatology and Allergy, Humboldt-University, Charite, Berlin, Germany. [email protected]
A new approach to completely autologous cardiovascular tissue in humans
2002
ASAIO J 2002 ;48 (3):234-8 |
A new technique for three-dimensional measurements of skin surface contours: evaluation of skin surface contours according to the ageing process using a stereo image optical topometer
2002
Physiol Meas 2002 ;23 (2):247-59 | Department of Electronics and Information Engineering, Korea University, Choongnam, Seoul, Korea.
Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products
2002
Food Chem Toxicol 2002 ;40 (5):573-92 | Human & Environmental Safety Division, The Procter & Gamble Co., Miami Valley Laboratories, Cincinnati, OH, USA. [email protected]
Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics
2002
Toxicol In Vitro 2002 ;16 (5):557-72 | Cosmital SA (Research Company of Wella AG, Germany), Rte de Chesalles 21, CH-1723 Marly, Switzerland. [email protected]
Reconstructed skin kits: reproducibility of cutaneous irritancy testing
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):74-91 | Cosmital SA (Research Company of Wella AG, Germany), Marly, Switzerland. [email protected]
Use of differential display-polymerase chain reaction to identify genes selectively modulated by chemical allergens in reconstituted human epidermis
2002
Toxicol In Vitro 2002 ;16 (4):427-31 | Laboratory of Toxicology, Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy. [email protected]
Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation
2002
Pharm Res 2002 ;19 (5):669-75 | Faculty of Pharmaceutical Sciences, Josai University, Sakado, Saitama, Japan.
Peaux reconstruites : les modeles se perfectionnent
2002
Archives for dermatological research 2002 ;162):46-65 |
Effect of squalene monohydroperoxide on cytotoxicity and cytokine release in a three-dimensional human skin model and human epidermal keratinocytes
2002
Toxicology in vitro 2002 ;16 (4):427-431 | National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
Characterization of the barrier function in a reconstituted human epidermis cultivated in chemically defined medium
2002
International journal of cosmetic science 2002 ;24 (1):25-34 | Lancaster Group - COTY International Research Center, Monaco; Dermo-Pharmacology and Cosmetology Research Unit, Faculty of Pharmacy, Chatenay-Malabry, France
Lack of desquamation: the Achilles heel of the reconstructed epidermis
2002
Toxicology in vitro 2002 ;24 (5):263-272 | Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands
ECVAM, ECETOC and the EU Chemicals Policy. Alternatives to animal experiments: Progress made and challenges ahead. The proceedings of the ECVAM Status Seminar 2002, held on 4-6 June 2002, in the amphitheatre at the European Commission Joint Research Centr
2002
ATLA Alternatives to laboratory animals 2002 ;30 (SUP2):185-187 | Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, SK10 4TJ, United Kingdom
Validation successes: Chemicals. Alternatives to animal experiments: Progress made and challenges ahead. The proceedings of the ECVAM Status Seminar 2002, held on 4-6 June 2002, in the amphitheatre at the European Commission Joint Research Centre (JRC), I
2002
ATLA Alternatives to laboratory animals 2002 ;30 (SUP2):33-40 | National Centre for Documentation and Evaluation of Alternative Methods to Animal Experiments (ZEBET), Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV), Diedersdorfer Weg 1, 12277 Berlin, Germany
Fibroblasts play a regulatory role in the control of pigmentation in reconstructed human skin from skin types I and II
2002
Pigment Cell Res 2002 Feb ;15 (1):49-56 | University Section of Medicine, Division of Clinical Sciences, Northern General Hospital, Sheffield, UK.